About 300 reports

  • HODGKIN LYMPHOMA
  • NON-HODGKIN LYMPHOMA
  • Lymphoma
  • Transplantation
  • World
  • Forecast
  • Merck & Co., Inc.
  • Diagnosis of lymphoma
  • Tests for lymphoma
  • Lymphoma
  • Forecast
  • Celgene Corporation
  • Seattle Genetics, Inc.
  • Takeda Pharmaceutical Company Limited

Key Features of the Report: - Non-Hodgkins Lymphoma Patient Flow - Non-Hodgkins Lymphoma Prevalence - Non-Hodgkins Lymphoma Diagnosed Patients - Non-Hodgkins Lymphoma Treated Patients

  • Lymphoma
  • Europe
  • France
  • World
  • Forecast
  • 9.27 Lymphoma, Hodgkin's - Market & Forecast
  • 9.28 Lymphoma, Non-hodgkin's - Market & Forecast
  • Lymphoma
  • North America
  • United States
  • Forecast
  • Market Size
  • Lymphoma Treatment Drugs Sales Volume
  • Lymphoma Treatment Drugs Sales Volume
  • Lymphoma
  • China
  • Beijing Wintic Pharma Co., Ltd
  • Shandong Luoxin Pharmacy Stock Co., Ltd.
  • Zhejiang Hisun Pharmaceutical Co., Ltd.

Hodgkin Lymphoma Market Forecast ($), Japan, 2015 - 2020 The latest research from Fore Pharma, Global Hodgkin Lymphoma Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Hodgkin Lymphoma pipeline products, Hodgkin Lymphoma epi

  • Lymphoma
  • France
  • Germany
  • Italy
  • Market Size

Non-Hodgkin Lymphoma Market Forecast ($), Japan, 2015 - 2020 The latest research from Fore Pharma, Global Non-Hodgkin Lymphoma Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Non-Hodgkin Lymphoma pipeline products, Non-Hodgkin

  • Lymphoma
  • France
  • Germany
  • Italy
  • Market Size
  • Marketed Drugs: Follicular Lymphoma
  • Pipeline: Follicular Lymphoma
  • Lymphoma
  • Europe
  • Japan
  • Biogen Idec Inc.
  • Roche Group
  • Epidemiology: Mantle Cell Lymphoma
  • TREATMENT: MANTLE CELL LYMPHOMA
  • Lymphoma
  • Europe
  • Celgene Corporation
  • Pfizer Inc.
  • Roche Group
  • Ann Arbor staging used in lymphoma
  • NON-HODGKIN'S LYMPHOMA IS SLIGHTLY MORE COMMON IN MALES
  • Lymphoma
  • Europe
  • Japan
  • Celgene Corporation
  • Roche Group
  • 5.2.6 LYMPHOMA
  • INCYTE CORPORATION
  • Lymphoma
  • AbbVie Inc.
  • Amgen Inc.
  • Biogen Idec Inc.
  • Bristol-Myers Squibb Company
  • Lymphoma Treatment Drugs Exports
  • Other Lymphoma Treatment Drugs
  • Lymphoma
  • China
  • Demand
  • Trade
  • Pfizer Inc.

Key Features of the Report: - Non-Hodgkin' s Lymphoma: Disease Definition - Non-Hodgkin' s Lymphoma Patient Flow - Non-Hodgkin' s Lymphoma Prevalence - Non-Hodgkin' s Lymphoma Diagnosed Patients - Non-Hodgkin' s Lymphoma Treated Patien

  • Lymphoma
  • Europe
  • France
  • World
  • Forecast
  • 3.5.1 Follicular Lymphoma
  • 3.5.2 Marginal Zone Lymphoma
  • Lymphoma
  • Germany
  • Japan
  • Spain
  • Forecast
  • EMERGENCE OF ADCS
  • APPENDIX
  • Lymphoma
  • Hoffmann-La Roche Inc.
  • ImmunoGen, Inc.
  • Seattle Genetics, Inc.
  • Takeda Pharmaceutical Company Limited
  • III. LYMPHOMA
  • Lymphoma Treatment Drugs Sales Volume
  • Lymphoma
  • China
  • Beijing Wintic Pharma Co., Ltd
  • Ltd Jiangsu Hengrui Medicine Co.
  • Ltd Shenzhen Main Luck Pharmaceuticals Inc.

Key Features of the Report: - Non-Hodgkins Lymphoma Patient Flow - Non-Hodgkins Lymphoma Prevalence - Non-Hodgkins Lymphoma Diagnosed Patients - Non-Hodgkins Lymphoma Treated Patients

  • Lymphoma
  • Europe
  • France
  • Germany
  • Forecast
  • For Hodgkin's lymphoma
  • LYMPHOMA (CHL)
  • Lymphoma
  • United States
  • Demand
  • Seattle Genetics, Inc.
  • Takeda Pharmaceutical Company Limited

(% market share) CHAPTER ##: PIPELINE DISRUPTORS: LYMPHOMA MARKET OPPORTUNITY Non-Hodgkin' s Lymphoma Table ##-##: Classification of Non-Hodgkin' s Lymphomas Hodgkin' s Lymphoma Figure ##-##: Global Incidence and Mortality of Lymphoma by Cou

  • Lymphoma
  • Oncology
  • Pathology
  • World
  • Market Size
  • 6.27 Lymphoma, Hodgkin's - Market & Forecast
  • 6.28 Lymphoma, Non-hodgkin's - Market & Forecast
  • Lymphoma
  • North America
  • United States
  • Forecast
  • Mitsubishi Corporation
  • CLASSIFICATION OF NON-HODGKIN'S LYMPHOMAS
  • LYMPHOMA MARKET BY DRUG TYPE ($ MILLIONS)
  • Lymphoma
  • AstraZeneca PLC
  • Novartis AG
  • Pfizer Inc.
  • Roche Group

Japan Hodgkin Lymphoma Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Hodgkin Lymphoma Treatments ##) Hodgkin Lymphoma Pipeline ##) Japan Hodgkin Lymphoma Epidemiology ##) Marketed Drugs for Hodgk

  • Cancer
  • Lymphoma
  • Pathology
  • Japan
  • Market Size

Japan Non-Hodgkin Lymphoma Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Non-Hodgkin Lymphoma Treatments ##) Non-Hodgkin Lymphoma Pipeline ##) Japan Non-Hodgkin Lymphoma Epidemiology ##) Marketed

  • Cancer
  • Lymphoma
  • Pathology
  • Japan
  • Market Size

Large Cell Lymphoma - Market Overview ##.

  • Cancer
  • Lymphoma
  • Market Size

Non-Hodgkin Lymphoma Market Forecast ($), UK, 2015 - 2020 The latest research from Fore Pharma, Europe Non-Hodgkin Lymphoma Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Non-Hodgkin Lymphoma pipeline products, Non-Hodgkin

  • Lymphoma
  • Europe
  • France
  • Germany
  • Market Size

Hodgkin Lymphoma Market Forecast ($), UK, 2015 - 2020 The latest research from Fore Pharma, Europe Hodgkin Lymphoma Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Hodgkin Lymphoma pipeline products, Hodgkin Lymphoma epidem

  • Lymphoma
  • Europe
  • France
  • Germany
  • Market Size

Italy Hodgkin Lymphoma Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Hodgkin Lymphoma Treatments ##) Hodgkin Lymphoma Pipeline ##) Italy Hodgkin Lymphoma Epidemiology ##) Marketed Drugs for Hodgk

  • Cancer
  • Lymphoma
  • Pathology
  • Italy
  • Market Size

Italy Non-Hodgkin Lymphoma Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Non-Hodgkin Lymphoma Treatments ##) Non-Hodgkin Lymphoma Pipeline ##) Italy Non-Hodgkin Lymphoma Epidemiology ##) Marketed

  • Cancer
  • Lymphoma
  • Pathology
  • Italy
  • Market Size

France Hodgkin Lymphoma Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Hodgkin Lymphoma Treatments ##) Hodgkin Lymphoma Pipeline ##) France Hodgkin Lymphoma Epidemiology ##) Marketed Drugs for Hod

  • Cancer
  • Lymphoma
  • Pathology
  • France
  • Market Size

UK Non-Hodgkin Lymphoma Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Non-Hodgkin Lymphoma Treatments ##) Non-Hodgkin Lymphoma Pipeline ##) UK Non-Hodgkin Lymphoma Epidemiology ##) Marketed Drugs

  • Cancer
  • Lymphoma
  • Pathology
  • United Kingdom
  • Market Size